Full-Time

2025 Analyst

Investment Banking

Posted on 10/31/2025

MTS Health Partners

MTS Health Partners

51-200 employees

Healthcare-focused M&A and financing advisor

Compensation Overview

$110k/yr

New York, NY, USA

In Person

Category
Finance & Banking (1)
Requirements
  • Candidates should have a strong desire to work in investment banking and an interest in the healthcare industry.
  • Demonstrated leadership in academics and extracurricular activities.
  • A degree from a top rated institution.
  • Strong quantitative and qualitative analytical skills.
  • Knowledge of corporate finance.
  • Keen attention to detail.
  • Commitment to contributing to the MTS team culture.
Responsibilities
  • Conduct company and industry research, performing financial and valuation analyses, creating business profiles, and preparing industry overviews on subsectors within the healthcare industry.
  • Create detailed financial models used for valuation and other financial analysis including discounted cash flow, leveraged buyout, mergers and acquisitions, accretion/dilution, and comparable company and transaction analysis.
  • Prepare marketing documents, including pitch materials, confidential offering memoranda, management presentations, fairness opinions and board presentations.
  • Conduct extensive financial and industry due diligence to evaluate the risk/return parameters of a transaction.

MTS Health Partners focuses on strategic and financial advisory for the healthcare industry. It advises on mergers and acquisitions, capital raising, and strategic consulting, and may execute transactions with equity and structured financing, charging fees for its advisory services. The firm operates by delivering tailored, candid guidance and transaction execution to healthcare clients such as pharmaceutical companies, biotech firms, and healthcare service providers, aiming to help them pursue strategic partnerships and build long-term value. Compared to competitors, it differentiates itself through its exclusive healthcare focus, a track record of 282 transactions totaling over $121 billion, and a relationship-driven approach that emphasizes creative thinking and results-oriented advice. Its goal is to create long-term value for clients by delivering strategic partnerships and financial solutions tailored to the healthcare sector.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

New York City, New York

Founded

1999

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing healthcare technology and value-based care demand expands MTS's advisory mandate and deal flow.
  • Increased private equity activity in healthcare boosts MTS's sponsor-driven M&A and capital raising.
  • MTS's life sciences practice captured over $50 billion in 2023 deal value, signaling strong market positioning.

What critics are saying

  • Heavy reliance on biotech and pharma M&A exposes MTS to funding winters and valuation compression.
  • Rapid hiring has raised fixed costs; a drop in deal volume would pressure margins and partner economics.
  • Exclusive focus on healthcare leaves MTS vulnerable to sector-wide downturns or regulatory shocks.

What makes MTS Health Partners unique

  • MTS Health Partners focuses exclusively on healthcare, giving it deep sector expertise and relationships.
  • The firm combines M&A advisory with equity and structured financing capabilities tailored to healthcare companies.
  • MTS differentiates through long-term client relationships and senior bankers with decades of healthcare experience.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Health Insurance

401(k) Retirement Plan

401(k) Company Match

Unlimited Paid Time Off

Paid Vacation

Flexible Work Hours

Wellness Program

Mental Health Support

Conference Attendance Budget

Professional Development Budget

Family Planning Benefits

Fertility Treatment Support

Stock Options

Company Equity

Phone/Internet Stipend

Home Office Stipend

Hybrid Work Options

Company News

The Andalusia Star-News
Sep 23rd, 2024
Healthcare Investment Banker Aaron Schwimmer Joins MTS Health Partners as Partner in Life Sciences Group

NEW YORK, Sept. 23, 2024 /PRNewswire/ - MTS Health Partners ("MTS") announced today that healthcare investment banker Aaron Schwimmer has joined their global life sciences practice as a Partner based in New York.

PR Newswire
Jun 17th, 2024
Evan Matlin Joins Mts Health Partners As Partner In Life Sciences Group

Appointment Bolsters MTS' Global Life Sciences PracticeNEW YORK, June 17, 2024 /PRNewswire/ -- MTS Health Partners welcomes Evan Matlin as a Partner in the Life Sciences Group. Matlin's appointment marks a significant addition to the Firm's global life sciences practice, which secured the second-highest total M&A deal value in the biotech industry with $50+ billion in 2023. His experience in this sector, as well as the tools and diagnostics sector, adds a dynamic new element to the Firm's advisory coverage.With a distinguished career spanning over 18 years, Matlin brings a wealth of practical knowledge to MTS Health Partners. Prior to joining MTS, and during his tenure at Barclays, Matlin was Co-Head of Healthcare M&A and spearheaded healthcare M&A efforts for the EMEA regions, playing a pivotal role in shaping the industry landscape. Over the course of his career, he has handled more than 50 completed transactions valued at over $225 billion.Curtis Lane, Founding Partner of MTS Health Partners, expressed his excitement about Matlin joining the team, stating, "Evan's proven track record and deep understanding of the healthcare sector make him a valuable asset to MTS. His global perspective will further enhance our ability to deliver strategic solutions to our clients."MTS Managing Partner Andrew Weisenfeld added, "Evan's appointment underscores our commitment to providing world-class advisory services to clients

PR Newswire
May 2nd, 2024
Mts Health Partners Adds Jason Schoenholtz As Healthcare Services Partner

Marks MTS' third new partner in the last 12 monthsNEW YORK, May 2, 2024 /PRNewswire/ -- MTS Health Partners is pleased to announce the addition of Jason Schoenholtz as Partner with the Firm. This strategic addition bolsters MTS' healthcare services team, demonstrating the Firm's commitment to expanding its capabilities and delivering exceptional value to clients in the rapidly evolving healthcare landscape."Jason's expertise across the healthcare sector aligns perfectly with our strategic vision of expanding the Firm's coverage while providing comprehensive solutions to our clients through deep content knowledge," said MTS Founding Partner Curtis Lane. "His addition reinforces our dedication to delivering innovative strategies and driving growth in the healthcare industry."In his role, Jason will identify new opportunities, navigate complex transactions, and drive value for clients across the healthcare services continuum. "I am thrilled to join MTS Health Partners and embark on this exciting new chapter in my career. The Firm's reputation for taking an innovative, client-centric approach, and commitment to excellence align perfectly with my own values and objectives. I am eager to leverage my experience and expertise to contribute to the Firm's continued success."Jason joins MTS from Lazard, where he focused on the healthcare supply chain including med-surg/drug distribution, durable medical equipment (DME), home medical supplies, pharmacy, pharma outsourcing, and medical/dental products.Jason holds a Bachelor of Science degree in Mechanical Engineering from the University of Vermont, a Master of Science in Bioengineering from the University of Pennsylvania, and an MBA in Finance and Healthcare Management from the Wharton School of the University of Pennsylvania

Google
Aug 14th, 2023
Daun Chung Joins MTS Health Partners

NEW YORK, Aug. 14, 2023 /PRNewswire/ -- MTS Health Partners ("MTS"), a leading healthcare-dedicated investment bank that provides strategic and financial advice to the global healthcare industry, announced today that Daun Chung has joined the firm as a Partner in its New York office.

PR Newswire
Jun 6th, 2023
Ryan Stewart Joins Mts Health Partners

Appointment Bolsters Firm's Deep Commitment to Healthcare Technology CoverageNEW YORK, June 6, 2023 /PRNewswire/ -- MTS Health Partners ("MTS"), a leading healthcare-dedicated investment bank that provides strategic and financial advice to the global healthcare industry, announced today that Ryan Stewart has joined the firm as a Partner in its New York office. As a key member of the MTS team, Ryan will work with Michael Ludwig to drive the firm's strategic initiatives in the rapidly evolving healthcare technology sector and expand the firm's industry-leading Healthcare Technology team.Ryan brings more than 25-years of industry experience and expertise, having worked in the healthcare technology field as an operating executive, management consultant, equity research analyst and investment banker. With more than 15-years in investment banking, most recently as a Managing Director at Solomon Partners, and prior to that as a Managing Director at SVB Securities, he brings unique experience and deep relationships across the sector, having built and led both firms' Healthcare Technology & Tech-Enabled Services practices.Appointment of Ryan Stewart Bolsters MTS' Deep Commitment to Healthcare Technology Coverage Tweet this"We are thrilled to welcome Ryan to the MTS team," said Curtis Lane, Founding Partner of MTS. "I have known and followed Ryan's career for many years, and his hiring reflects our commitment to expand our expertise in healthcare technology and reinforces our position as an industry leading advisor.""I am deeply honored to join MTS," said Ryan. "I am very excited to collaborate with my new partners on scaling our healthcare technology presence across the core and essential end-markets of healthcare, including care delivery, value-based care, managed care, provider-tech, pharma-tech and the emerging application of data & analytics across the entire industry."Over the past 18-months, Ryan has advised on ~$2 billion of M&A volume, including the sale of Panalgo to WCAS and Hg-owned MMIT/Evaluate; the sale of Patient Funding Alternatives to Leonard Green & Partners; the $1.35 billion purchase of MagellanRx by Prime Therapeutics; and the sale of Prodigo Solutions to Temasek and Warburg Pincus-backed GHX.MTS has significant experience representing public and private healthcare companies on a broad range of transactions, including M&A and strategic advisory assignments, as well as privately negotiated financings across a wide range of structures. Most recently, the firm served as financial advisor to both CTI BioPharma on its $1.7 billion sale to Swedish Orphan Biovitrum (SOBI) and to Seagen on its $43 billion sale to Pfizer.About MTSMTS Health Partners is a leading healthcare-dedicated investment bank that provides strategic and financial advisory services to the global healthcare industry

INACTIVE